Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment ; volume:18 ; number:1 ; day:30 ; month:3 ; year:2019 ; pages:1-12 ; date:12.2019
Molecular cancer ; 18, Heft 1 (30.3.2019), 1-12, 12.2019
- Urheber
-
Yi, Ming
Jiao, Dechao
Qin, Shuang
Chu, Qian
Wu, Kongming
Li, Anping
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-019-0974-6
- URN
-
urn:nbn:de:101:1-2019042112365330781297
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yi, Ming
- Jiao, Dechao
- Qin, Shuang
- Chu, Qian
- Wu, Kongming
- Li, Anping
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Enhanced cancer immunotherapy through synergistic ferroptosis and immune checkpoint blockade using cell membrane-coated nanoparticles
Activation of phagocytosis by immune checkpoint blockade
The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Prospects for combining immune checkpoint blockade with PARP inhibition
Microbial biomarkers for immune checkpoint blockade therapy against cancer
Regulatory T cells in immune checkpoint blockade antitumor therapy
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Enhanced cancer immunotherapy through synergistic ferroptosis and immune checkpoint blockade using cell membrane-coated nanoparticles
Activation of phagocytosis by immune checkpoint blockade
The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Prospects for combining immune checkpoint blockade with PARP inhibition
Microbial biomarkers for immune checkpoint blockade therapy against cancer
Regulatory T cells in immune checkpoint blockade antitumor therapy
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Enhanced cancer immunotherapy through synergistic ferroptosis and immune checkpoint blockade using cell membrane-coated nanoparticles
Activation of phagocytosis by immune checkpoint blockade
The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Prospects for combining immune checkpoint blockade with PARP inhibition
Microbial biomarkers for immune checkpoint blockade therapy against cancer
Regulatory T cells in immune checkpoint blockade antitumor therapy
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment